查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1654678

全球侧韧带稳定係统市场 - 2025 至 2033 年

Global Collateral Ligament Stabilizer System Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球侧韧带稳定係统市场规模达到 23.2 亿美元，预计到 2033 年将达到 41.1 亿美元，在 2025-2033 年预测期内的复合年增长率为 6.5%。

侧韧带稳定係统是一种专门的医疗设备，旨在为膝关节受伤或衰弱的侧韧带提供支撑、稳定性和调整。这些韧带，包括内侧副韧带 (MCL) 和外侧副韧带 (LCL)，透过防止过度的左右运动在维持关节稳定性方面发挥至关重要的作用。这些韧带的损伤在运动相关活动、事故或因退化状况而发生很常见，导致疼痛、肿胀和关节不稳定。

市场动态：

驱动因素与约束因素

运动伤害发生率不断上升

由于全球运动相关伤害（尤其是膝盖伤害）的增加，侧韧带稳定係统市场正在成长。足球、篮球、滑雪和橄榄球等高强度运动需要快速改变方向和身体接触，因此运动员容易受到伤害。健身潮流和竞技运动的火爆，进一步增加了韧带相关损伤的风险。这推动了对先进稳定係统的需求，以帮助运动员更快地恢復、保持关节稳定并降低再次受伤的风险。

例如，日本大学运动员运动伤害的发生率很高，其中一半报告受伤，45％报告多次受伤。这一比例超过了其他国家报告的普通人群和体育人群的数字。在德国，3.1% 的成年人报告在过去一年中遭受运动伤害，而在丹麦，18.4% 的成年人和 19.3% 的儿童报告在过去 12 个月内遭受运动伤害。芬兰青少年报告称，在过去一年中至少发生过一次急性或过度使用损伤。巴西运动员报告称，在其 6 至 10 年的医学研究中，受伤发生率为 49%，而不是像目前研究中的运动员一样在一年内发生。

新兴地区的认知有限和诊断延迟

由于对韧带损伤的认识有限和诊断延迟，侧韧带稳定係统市场面临挑战，尤其是在新兴和欠发达地区。农村居民可能无法认识到伤害的严重性或将症状归咎于轻微的拉伤，从而导致延误寻求适当的医疗救治。缺乏专业的骨科护理和诊断设施进一步导致诊断不足和治疗不足，减少了对稳定係统的需求并阻碍了市场成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 运动伤害发生率不断上升
    • 限制
      • 新兴地区的认知有限和诊断延迟
    • 机会
    • 影响分析

第五章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：按韧带类型

  • 内侧副韧带 (MCL)
  • 外侧副韧带 (LCL)

第 7 章：按伤害类型

  • 一级（轻度）
  • 二级（中）
  • 三级（严重）

第 8 章：按最终用户

  • 医院
  • 骨科诊所
  • 其他的

第九章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Bauerfeind.
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Enovis (DJO Global, Inc.)
  • DeRoyal Industries
  • Ossur hf.
  • DARCO International, Inc.
  • Orthofix US LLC (Breg, Inc.)
  • Thuasne USA
  • Bio Dynamic Technologies
  • BSN Medical
  • Similar data will be provided for each market player.
  • 布雷格公司
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • 科林集团
  • 将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录
Product Code: MD9128

The Global Collateral Ligament Stabilizer System Market reached US$ 2.32 Billion in 2024 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.5% during the forecast period 2025-2033.

The Collateral Ligament Stabilizer System is a specialized medical device designed to provide support, stability, and alignment to injured or weakened collateral ligaments, primarily in the knee joint. These ligaments, including the medial collateral ligament (MCL) and lateral collateral ligament (LCL), play a crucial role in maintaining the joint's stability by preventing excessive side-to-side movements. Injuries to these ligaments are common in sports-related activities, accidents, or due to degenerative conditions, leading to pain, swelling, and joint instability.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Sports-related Injuries

The Collateral Ligament Stabilizer System market is growing due to the rise in sports-related injuries globally, particularly in knees. High-impact sports like football, basketball, skiing, and rugby involve rapid directional changes and physical contact, making athletes susceptible. The popularity of fitness trends and competitive sports has further increased the risk of ligament-related injuries. This has driven the demand for advanced stabilizer systems that aid in faster recovery, joint stability, and reduced risk of reinjury in athletes.

For instance, The prevalence of sports injuries among Japanese collegiate athletes is high, with half reporting an injury and 45% sustaining multiple injuries. This rate exceeds numbers reported for general and sports populations in other countries. In Germany, 3.1% of adults reported sustaining a sports injury in the previous year, while in Denmark, 18.4% of adults and 19.3% of children reported having a sports injury within the past 12 months. Finnish adolescents reported at least one acute or overuse injury in the previous year. Brazilian athletes reported an injury prevalence of 49% over 6-10 years of their medical studies, not within a year like the athletes in the current study.

Limited Awareness and Delayed Diagnosis in Emerging Regions

The collateral ligament stabilizer system market faces challenges due to limited awareness and delayed diagnosis of ligament injuries, particularly in emerging and underdeveloped regions. Rural individuals may not recognize the severity of injuries or attribute symptoms to minor strains, leading to delays in seeking proper medical attention. Lack of access to specialized orthopedic care and diagnostic facilities further contributes to underdiagnosis and undertreatment, reducing demand for stabilizer systems and hindering market growth.

Segment Analysis

The global Collateral Ligament Stabilizer System market is segmented based on, Ligament Type, Injury Type, End User and Region.

Ligament Type:

Medial Collateral Ligament (MCL) segment is expected to dominate the Collateral Ligament Stabilizer System market share

The medial collateral ligament (MCL) segment holds a major portion of the Collateral Ligament Stabilizer System market share and is expected to continue to hold a significant portion of the Collateral Ligament Stabilizer System market share during the forecast period.

The Medial Collateral Ligament (MCL) is a crucial ligament in the knee joint, connecting the femur to the tibia and resisting valgus forces. Injuries to the MCL are common, especially in contact sports like football, hockey, and skiing. The increasing prevalence of MCL injuries has led to a demand for Collateral Ligament Stabilizer Systems, designed to provide targeted support, reduce stress, and promote healing. As awareness of sports-related injuries increases and diagnostic techniques improve, the focus on MCL-specific stabilizers continues to drive market growth.

End User:-

Hospitals segment is the fastest-growing segment in Collateral Ligament Stabilizer System market share

The hospitals segment is the fastest-growing segment in the Collateral Ligament Stabilizer System market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the Collateral Ligament Stabilizer System market, providing diagnosis, treatment, and rehabilitation for ligament injuries. They use advanced imaging technologies and specialized orthopedic departments for early detection and management. Hospitals perform numerous surgical procedures, particularly in severe ligament tears requiring post-operative support. The presence of skilled healthcare professionals and comprehensive rehabilitation programs drives the adoption of advanced stabilizer systems. The growing number of sports injury cases and improvements in hospital infrastructure further contribute to the market's growth.

Geographical Analysis

North America is expected to hold a significant position in the Collateral Ligament Stabilizer System market share

North America holds a substantial position in the Collateral Ligament Stabilizer System market and is expected to hold most of the market share due to high sports-related injuries and increasing orthopedic procedures. The region's strong sports culture, advanced medical technologies, and awareness about injury management contribute to market growth. Favourable reimbursement policies, extensive research and development activities, and key market players further accelerate the adoption of advanced stabilizer systems in the region. The region's well-established healthcare infrastructure and advanced medical technologies further drive market growth.

For instance, according to The Johns Hopkins Hospital, and Johns Hopkins Health System, over 3.5 million children aged 14 and younger are injured annually in sports or recreational activities, with brain injuries being the leading cause of death. Sports and recreational activities contribute to 21% of all traumatic brain injuries among American children. Almost 50% of head injuries in sports or recreational activities occur during incidents like bicycling, skateboarding, or skating. Over 775,000 children are treated for sports-related injuries annually, primarily due to falls, object strikes, collisions, and overexertion during unorganized or informal sports activities.

Europe is growing at the fastest pace in the Collateral Ligament Stabilizer System market

Europe holds the fastest pace in the Collateral Ligament Stabilizer System market and is expected to hold most of the market share is due to the growing focus on sports injury prevention and rehabilitation, orthopedic care advancements, and the popularity of activities like soccer, skiing, and rugby. Strong healthcare policies, government initiatives, and access to innovative medical devices like CE marking contribute to market growth. The aging population and collaborations between research institutions and medical device companies further support the market expansion across Europe.

For instance, according to The Johns Hopkins Hospital Sports injuries in the UK are prevalent, with around 2 million people visiting Accident & Emergency departments annually due to these injuries, resulting from various activities such as team sports like football and rugby, as well as individual physical activities like running and gym workouts.

Competitive Landscape

The major global players in the Collateral Ligament Stabilizer System market include Bauerfeind, Enovis (DJO Global, Inc.), DeRoyal Industries, Ossur hf, DARCO International, Inc., Orthofix US LLC (Breg, Inc.), Thuasne USA, Bio Dynamic Technologies, BSN Medical and among others.

Key Developments

  • In January 2024, Enovis has acquired Limacorporate, a company specializing in orthopedic implants, thereby strengthening its market dominance in the rapidly growing extremities market segment, with the acquisition of Limacorporate's 3D-printed Trabecular Titanium implants.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Collateral Ligament Stabilizer System market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Ligament Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Ligament Type
  • 3.2. Snippet by Injury Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Sports-related Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness and Delayed Diagnosis in Emerging Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Ligament Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 6.1.2. Market Attractiveness Index, By Ligament Type
  • 6.2. Medial Collateral Ligament (MCL)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Lateral Collateral Ligament (LCL)

7. By Injury Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 7.1.2. Market Attractiveness Index, By Injury Type
  • 7.2. Grade I (Mild)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Grade II (Moderate)
  • 7.4. Grade III (Severe)

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedic Clinics
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Bauerfeind.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Enovis (DJO Global, Inc.)
  • 11.3. DeRoyal Industries
  • 11.4. Ossur hf.
  • 11.5. DARCO International, Inc.
  • 11.6. Orthofix US LLC (Breg, Inc.)
  • 11.7. Thuasne USA
  • 11.8. Bio Dynamic Technologies
  • 11.9. BSN Medical
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.10. Breg, Inc*
    • 11.10.1. Pipeline Products Description
    • 11.10.2. Product Key Performance Indicators (KPIs)
    • 11.10.3. Key Activities
    • 11.10.4. Market Entry Timelines
    • 11.10.5. Product Penetration Rate
    • 11.10.6. Sales Estimation and Projections
  • 11.11. Corin Group
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us